49 results on '"Yao, Huilan"'
Search Results
2. Study on energy harvest performance of a flapping hydrofoil with swept leading edges by numerical methods
3. Vortex-body interaction of a hybrid pitching circular motion hydrofoil turbine and the performance
4. Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms.
5. Numerical Study of Stern Vibration of a Self-Propulsion Ship in Propeller Induced Pressure Fluctuation
6. Comparative study on hydrodynamic performance and induced pressure of new canard tandem propellers and conventional propellers
7. SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia
8. Numerical investigation on hydrodynamic performance of new canard-configuration tandem propellers
9. Ixazomib plus daratumumab and dexamethasone: Final analysis of a phase 2 study among patients with relapsed/refractory multiple myeloma
10. Flow physics behind the wake of a flapping hydrofoil turbine near a wall.
11. A simple method for estimating transition locations on blade surface of model propellers to be used for calculating viscous force
12. Wake physics of two-dimensional flapping-hydrofoil turbines
13. Numerical study of flow-excited noise of a submarine with full appendages considering fluid structure interaction using the boundary element method
14. H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers
15. Numerical simulation of boundary-layer transition flow of a model propeller and the full-scale propeller for studying scale effects
16. S110: PHALLCON: A PHASE 3 STUDY COMPARING PONATINIB VERSUS IMATINIB IN NEWLY DIAGNOSED PH+ ALL
17. Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia
18. Data from Pharmacologic Activation of STING in the Bladder Induces Potent Antitumor Immunity in Non–Muscle Invasive Murine Bladder Cancer
19. Supplementary Table from Pharmacologic Activation of STING in the Bladder Induces Potent Antitumor Immunity in Non–Muscle Invasive Murine Bladder Cancer
20. Supplementary Figure from Pharmacologic Activation of STING in the Bladder Induces Potent Antitumor Immunity in Non–Muscle Invasive Murine Bladder Cancer
21. Correction: Pharmacologic Activation of STING in the Bladder Induces Potent Antitumor Immunity in Non–Muscle Invasive Murine Bladder Cancer
22. Safety and Pharmacokinetics (PK) of BLU-808 Following Oral Dosing in Healthy Volunteers
23. Vortex-Body Interaction of a Hybrid Pitching Circular Motion Hydrofoil Turbine and the Performance
24. Corepressor Rcor1 is essential for murine erythropoiesis
25. Efficacy and Safety of Oral Ixazomib (Ixa), Intravenous (IV) Daratumumab (Dara), and IV/Oral Dexamethasone (Dex; IDd) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM) and 1-3 Prior Therapies: Results of the Final Analysis of a Phase 2 Study
26. Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A
27. A cross‐sectional observational study on the level of diabetes knowledge and related influencing factors among orthopaedic nurses
28. An accurate and stable alternating directional moving particle semi-implicit method for incompressible flow simulation
29. Pharmacologic Activation of STING in the Bladder Induces Potent Antitumor Immunity in Non–Muscle Invasive Murine Bladder Cancer
30. Association of continuous glucose monitoring-derived time in range with major amputation risk in diabetic foot osteomyelitis patients undergoing amputation
31. A cross‐sectional observational study on the level of diabetes knowledge and related influencing factors among orthopaedic nurses.
32. Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia (10.1038/s41375- 021-01273-7):SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia (Leukemia, (2021), 35, 9, (2698-2702), 10.1038/s41375-021-01273-7)
33. Abstract PS12-23: Development of H3B-6545, a first-in-class oral selective ER covalent antagonist (SERCA), for the treatment of ERaWTand ERaMUTbreast cancer
34. Biodegradation studies of poly(3-hydroxybutyrate- co-3-hydroxyhexanoate)
35. Results of a Clinical Trial of H3B-8800, a Splicing Modulator, in Patients with Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML)
36. Molecular characterization and monitoring of patient ctDNA in phase I study of H3B-6545 in ER+ MBC.
37. Coupling multiplex pre-amplification and droplet digital PCR for longitudinal monitoring ofESR1andPIK3CAmutations from plasma cell-free DNA
38. Numerical simulation of two experiments for studying propeller exciting forces
39. Abstract 1185: H3B-8800, a novel orally available SF3b modulator, shows preclinical efficacy across spliceosome mutant cancers
40. Numerical study of MPS method with large eddy simulation for fluid solid coupling problem
41. Numerical Studies of Propeller Exciting Bearing Forces under Nonuniform Ship’s Nominal Wake and the Influence of Cross Flows
42. Critical roles for the co-repressor, Rcor1, in lineage determination
43. Lines design research on environmental protection NOBS
44. The Corepressor Rcor1 Is Essential for Normal Myeloerythroid Lineage Differentiation
45. Rcor1 Deficiency Disrupts Myeloerythroid Lineage Differentiation and Causes Severe Myelodysplasia
46. Polycomb- and REST-associated histone deacetylases are independent pathways toward a mature neuronal phenotype
47. Author response: Polycomb- and REST-associated histone deacetylases are independent pathways toward a mature neuronal phenotype
48. Up-Regulation of Mitochondrial Activity and Acquirement of Brown Adipose Tissue-Like Property in the White Adipose Tissue of Fsp27 Deficient Mice
49. Up-Regulation of Mitochondrial Activity and Acquirement of Brown Adipose Tissue-Like Property in the White Adipose Tissue of Fsp27 Deficient Mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.